W. Toma

发表

Background and Purpose Experimental Approach Conclusions and Implications

R. Papke, A. Lichtman, G. Thakur, 2022 .

The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice

W. Toma, M. Damaj, A. Jackson, 2019, Pharmacology Biochemistry and Behavior.

N‐acylethanolamine‐hydrolysing acid amidase: A new potential target to treat paclitaxel‐induced neuropathy

M. Malamas, A. Makriyannis, A. Lichtman, 2021, European journal of pain.

Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy

D. Gewirtz, W. Toma, M. Damaj, 2021, Brain, Behavior, and Immunity.

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice

J. Bigbee, D. Gewirtz, X. Fang, 2020, Cancers.

The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.

W. Toma, S. AlSharari, H. M. Mahmood, 2020, European journal of pharmacology.

The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin test

W. Toma, M. Damaj, R. Uprety, 2020, Behavioural pharmacology.

Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.

J. McIntosh, W. Toma, S. AlSharari, 2020, Current topics in behavioral neurosciences.

Targeting Nicotinic Acetylcholine Receptors for the Treatment of Pain

D. Bagdas, W. Toma, M. Damaj, 2019, Neuroscience of Nicotine.

Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein

J. Bigbee, P. Knapp, D. Bagdas, 2022, Experimental Neurology.

Curcumin Acts as a Positive Allosteric Modulator of α7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain

D. Bagdas, W. Toma, M. Oz, 2018, The Journal of Pharmacology and Experimental Therapeutics.

The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice

R. Papke, A. Lichtman, G. Donvito, 2017, Experimental Neurology.

Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain

D. Bagdas, W. Toma, M. Damaj, 2018, European journal of pain.

Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse

J. Bigbee, A. Lichtman, D. Gewirtz, 2017, Neuropharmacology.

A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE

R. Papke, M. Quadri, N. Horenstein, 2019, Brain, Behavior, and Immunity.

Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN

J. Bigbee, A. Lichtman, D. Gewirtz, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Effects of chemotherapy on operant responding for palatable food in male and female mice

A. Lichtman, W. Toma, M. Damaj, 2021, Behavioural pharmacology.

Adolescent low-dose ethanol drinking in the dark increases ethanol intake later in life in C57BL/6J, but not DBA/2J mice.

W. Toma, M. Damaj, J. Wolstenholme, 2020, Alcohol.

Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy

A. Rice, P. Knapp, D. Bagdas, 2018, Pain reports.

The Antinociceptive and Anti-Inflammatory Properties of the α7 nAChR Weak Partial Agonist p-CF3 N,N-diethyl-N′-phenylpiperazine

R. Papke, C. Stokes, M. Quadri, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice

J. Bigbee, W. Toma, M. Damaj, 2021, Frontiers in Pain Research.

The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal

R. Papke, J. Bigbee, D. Gewirtz, 2019, Experimental Neurology.

Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms

C. D. Fowler, Sumanta Garai, G. Thakur, 2021, Neuropharmacology.

C57BL/6 Substrain Differences in Pharmacological Effects after Acute and Repeated Nicotine Administration

R. Tyndale, W. Toma, M. Damaj, 2019, Brain sciences.

Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy

D. Selley, W. Toma, M. Damaj, 2020, Psychopharmacology.

L-theanine attenuates nicotine reward and withdrawal signs in mice

W. Toma, M. Damaj, Y. Alkhlaif, 2023, Neuroscience Letters.

Formulated Curcumin Prevents Paclitaxel-Induced Peripheral Neuropathy through Reduction in Neuroinflammation by Modulation of α7 Nicotinic Acetylcholine Receptors

J. Bigbee, D. Gewirtz, W. Toma, 2022, Pharmaceutics.

Deficit in voluntary wheel running in chronic inflammatory and neuropathic pain models in mice: Impact of sex and genotype

D. Bagdas, W. Toma, M. Damaj, 2020, Behavioural Brain Research.

Investigating The Role of AEG-1 in Mouse Models of Pain

D. Bagdas, W. Toma, M. Damaj, 2020 .

Molecular and behavioral mechanisms mediating paclitaxel‐induced changes in affect‐like behavior in mice

D. Selley, D. Bagdas, W. Toma, 2019, The FASEB Journal.